Mcl-1 (RC13) Antibody sc-56152 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemMcl-1 (RC13) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-56152
Antibody TypePrimary Antibodies
NCBI Gene AliasesBCL2L3, MCL1S, MCL1-ES, mcl1/EAT, Mcl-1, bcl2-L-3, MCL1L, Gm52627, EAT, TM
Quantity200 µg/ml
CloneRC13
Reactivityhuman > mouse, rat
ApplicationsWB, IP, IF, IHC(P)
Conjugate/TagUnconjugated
ClonalityMonoclonal
FormatPurified
Hostmouse
NCBI Full Gene Namemyeloid cell leukemia sequence 1, MCL1 apoptosis regulator, BCL2 family member
TargetMcl-1
IsotypeIgG1

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on MechanismLymphaticsDecember 12, 2024Hyunjoo Lee, Shabirul Haque, Rashmi Gupta, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi, Patricia K. A. Monginianti-MCL1 (clone 22; BD Pharmingen or clone RC13; Santa Cruz Biotechnology, Paso Robles, CA, USA; cat# sc-56152); and anti-survivin (clone D8; Santa Cruz Biotech cat #sc-17779). This protocol detects cytoplasmic

(2) MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73Cell death & diseaseNovember 3, 2020Widden H, Kaczmarczyk A, Subedi A, Whitaker RH, Placzek WJ.

(3) Nitidine chloride represses Mcl-1 protein via lysosomal degradation in oral squamous cell carcinomaJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral PathologyOctober 1, 2018Yang IH, Jung W, Kim LH, Shin JA, Cho NP, Hong SD, Hong KO, Cho SD.

(4) Structural Mechanism for Regulation of Bcl-2 protein Noxa by phosphorylationScientific reportsSeptember 28, 2015Karim CB, Espinoza-Fonseca LM, James ZM, Hanse EA, Gaynes JS, Thomas DD, Kelekar A.

(6) Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerSeptember 1, 2014Schmidt LH, Görlich D, Spieker T, Rohde C, Schuler M, Mohr M, Humberg J, Sauer T, Thoenissen NH, Huge A, et al.

(10) Therapeutic efficacy of the pan-cdk inhibitor PHA-793887 in vitro and in vivo in engraftment and high-burden leukemia modelsExperimental hematologyApril 1, 2010Alzani R, Pedrini O, Albanese C, Ceruti R, Casolaro A, Patton V, Colotta F, Rambaldi A, Introna M, Pesenti E, et al.

Mcl-1 (RC13) Antibody